Target intelligence / Profile preview

RNY1 pseudogene 1 (RNY1P1)

Target
RNY1P1
Molecular classification
Pseudogene, Non-coding RNA, Small Y RNA pseudogene
01

Overview

RNY1 pseudogene 1 (RNY1P1) is a non-coding, processed pseudogene of the RNY1 gene, which encodes a small Y RNA that is a component of Ro ribonucleoprotein (RNP) complexes, important in RNA quality control and implicated in autoimmune diseases such as systemic lupus erythematosus[3][1]. As a pseudogene, RNY1P1 does not produce a functional RNA or protein and is generally considered non-functional; however, more broadly, pseudogene transcripts can sometimes modulate gene regulation post-transcriptionally by acting as competing endogenous RNAs (ceRNAs) that sponge microRNAs, or by altering mRNA stability by binding RNA-binding proteins[4][2]. There is no clear evidence that RNY1P1 specifically acts in such a manner, and it is not currently considered a therapeutic target or a biomarker, nor is it associated with drug interactions. RNY1P1 does not encode for a receptor, enzyme, transporter, or any canonical drug target class. Its main relevance lies in genomics and transcriptomics as part of non-coding RNA and pseudogene studies[4][2][3].

Other names
RNA, Ro-associated Y1 pseudogene 1RNY1P1
02

Biological functions

Acts as a pseudogene (non-functional, does not encode a protein)May regulate gene expression through RNA-based mechanisms such as serving as an RNA decoy or modulating RNA stability via competition with endogenous microRNAs or RNA-binding proteins
03

Disease associations

Other (pseudogene expression across tissues and cancers is an emerging field; specific disease relevance limited or unknown)

Beyond the preview

Go deeper on RNY1 pseudogene 1 (RNY1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNY1 pseudogene 1 (RNY1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call